Stock DEX DEXTECH MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Dextech Medical AB

Equities

DEX

SE0005881489

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
4.04 SEK -3.35% Intraday chart for Dextech Medical AB +2.02% +2.80%
Apr. 26 Dextech Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Apr. 15 DexTech Medical Announces New Positive Results from the Myeloma Study CI

Business Summary

Dextech Medical AB is a Sweden-based research company specialized in urologic oncology. It is focused on prostate cancer, but also other cancers and non-malignant diseases. It develops drug canditates based on modified carbohydrate molecule combined with active substances. The Company has a patented technology platform, GuaDex, and three drug candidates with patents or patent applications. The portfolio includes: OsteoDex, for treatment of bone metastases in castration resistant prostate cancer (CRPC); SomaDex, based on endogenous hormone, somatostatin, and aimed at treatment of acromegaly, neuroendocrine tumors and palliative treatment of CRPC; and CatDex, for instillation treatment of bladder cancer.

Number of employees: 1

Managers

Managers TitleAgeSince
Anders Ragnarson Holmberg CEO
 Chief Executive Officer 73 04-04-20
Gösta Lundgren DFI
 Director of Finance/CFO 69 12-12-31

Members of the board

Members of the board TitleAgeSince
Peter James Arthur Benson BRD
 Director/Board Member 69 -
Andreas Segerros CHM
 Chairman 63 -
Svante Wadman BRD
 Director/Board Member 71 06-09-01
Rolf Weste Eriksson BRD
 Director/Board Member 72 14-03-23
Per-Olov Asplund BRD
 Director/Board Member 75 13-03-11
Anders Ragnarson Holmberg CEO
 Chief Executive Officer 73 04-04-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,485,857 7,158,151 ( 38.72 %) 0 38.72 %

Company contact information

Dextech Medical AB

Dag Hammarskjölds Väg 34A

752 37, Uppsala

+46 7 07 10 47 88

http://www.dextechmedical.com
address Dextech Medical AB(DEX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
DEXTECH MEDICAL AB Stock Dextech Medical AB
+2.80% 7.09M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+20.12% 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+25.25% 119B
ARGENX SE Stock argenx SE
+25.56% 27.95B
BIONTECH SE Stock BioNTech SE
-19.51% 20.5B
GENMAB A/S Stock Genmab A/S
-14.36% 17.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.63% 16.1B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-46.67% 14.97B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+11.89% 14.84B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+57.74% 14.38B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. DEX Stock
  4. Company Dextech Medical AB